Clinical ink
Share on
CONTACT US: 1.336.714.7402

WHITE PAPER

Progress in a New Era: Digital Biomarkers as Endpoints in Parkinson’s Disease

Clinical ink advances a new age of discovery in Parkinson’s research.

Clinicalink Parkinsons Disease Whitepaper_mockup

Parkinson's research is evolving, with a dramatic increase in patient involvement, advanced systems of measurement, and real-world data gathering at the forefront. Subjective assessments and endpoints can now be augmented with richer data sources gathered directly via wearables, sensors, and mobile technology.

Clinical ink is advancing a new age of clinical discovery in Parkinson’s research, deploying our data collection technology to sensitively and remotely assess, engage, and gather continuous data directly from patients for Parkinson’s clinical trials. These novel, rich data sources, coupled with our internal expertise in established assessments, are leading to groundbreaking digital biomarker advancement.

To learn more, download our white paper, Progress in a new Era of Digital Biomarkers as Endpoints in Parkinson’s Disease.

Download and Read This Resource Now